A Q-TWiST Analysis Comparing Nivolumab and Therapy of Investigator’s Choice in Patients with Recurrent/Metastatic Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck

被引：0
|
作者：
Kim Cocks
Marta Contente
Sarah Simpson
Michael DeRosa
Fiona C. Taylor
James W. Shaw
机构：
[1] Adelphi Values,
[2] Bristol-Myers Squibb,undefined
[3] BMS House,undefined
[4] Adelphi Values,undefined
[5] Bristol-Myers Squibb,undefined
来源：
PharmacoEconomics | 2019年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1041 / 1047
页数：6
相关论文
共 50 条
  • [1] A Q-TWiST Analysis Comparing Nivolumab and Therapy of Investigator's Choice in Patients with Recurrent/Metastatic Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck
    Cocks, Kim
    Contente, Marta
    Simpson, Sarah
    DeRosa, Michael
    Taylor, Fiona C.
    Shaw, James W.
    [J]. PHARMACOECONOMICS, 2019, 37 (08) : 1041 - 1047
  • [2] A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OF DISEASE AND TOXICITY (Q-TWIST) ANALYSIS COMPARING NIVOLUMAB AND THERAPY OF INVESTIGATOR'S CHOICE (IC) IN PATIENTS WITH RECURRENT OR METASTATIC (R/M) PLATINUM-REFRACTORY SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) (CHECKMATE 141)
    Simpson, S.
    Cocks, K.
    Contente, M.
    DeRosa, M.
    Taylor, F.
    Shaw, J. W.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A450 - A450
  • [3] Nivolumab for Platinum-refractory and -sensitive Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
    Okada, Takuro
    Matsuki, Takashi
    Fushimi, Chihiro
    Okamoto, Isaku
    Sato, Hiroki
    Kondo, Takahito
    Tokashiki, Kunihiko
    Ito, Tatsuya
    Masubuchi, Tatsuo
    Tada, Yuichiro
    Miura, Kouki
    Hanyu, Kenji
    Omura, Go
    Takahashi, Hideki
    Yamashita, Taku
    Oridate, Nobuhiko
    Tsukahara, Kiyoaki
    [J]. ANTICANCER RESEARCH, 2022, 42 (10) : 4907 - 4912
  • [4] Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
    Byoung Chul Cho
    Ki Chang Keum
    Sang Joon Shin
    Hye Jin Choi
    Young Joo Lee
    Se Hun Kim
    Eun Chang Choi
    Joo Hang Kim
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 65 : 27 - 32
  • [5] Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
    Cho, Byoung Chul
    Keum, Ki Chang
    Shin, Sang Joon
    Choi, Hye Jin
    Lee, Young Joo
    Kim, Se Hun
    Choi, Eun Chang
    Kim, Joo Hang
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) : 27 - 32
  • [6] TOPNIVO - A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of head and neck (R/M SCCHN): Final analysis
    Even, C.
    Daste, A.
    Fayette, J.
    Lefebvre, G.
    Saada-Bouzid, E.
    Zanetta, S.
    Toullec, C.
    Cupissol, D.
    Salas, S.
    Kaminski, M. C.
    Johnson, A. C.
    Vauleon, E.
    Le Tourneau, C.
    Sire, C.
    Prevost, A.
    Jallut, I.
    Bourhis, J.
    Guigay, J.
    Auperin, A.
    Texier, M.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S662 - S662
  • [7] A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma
    Bauman, Julie E.
    Arias-Pulido, Hugo
    Lee, Sang-Joon
    Fekrazad, M. Houman
    Ozawa, Hiroyuki
    Fertig, Elana
    Howard, Jason
    Bishop, Justin
    Wang, Hao
    Olson, Garth T.
    Spafford, Michael J.
    Jones, Dennie V.
    Chung, Christine H.
    [J]. ORAL ONCOLOGY, 2013, 49 (05) : 461 - 467
  • [8] Single-agent docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Zenda, Sadamoto
    Onozawa, Yusuke
    Boku, Narikazu
    Fida, Yoshiyuki
    Ebihara, Mitsuru
    Onitsuka, Tetsuro
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (07) : 477 - 481
  • [9] Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age
    Saba, Nabil F.
    Blumenschein, George, Jr.
    Guigay, Joel
    Licitra, Lisa
    Fayette, Jerome
    Harrington, Kevin J.
    Kiyota, Naomi
    Gillison, Maura L.
    Ferris, Robert L.
    Jayaprakash, Vijayvel
    Li, Li
    Brossart, Peter
    [J]. ORAL ONCOLOGY, 2019, 96 : 7 - 14
  • [10] ANALYSES OF HEALTHCARE RESOURCE UTILIZATION (HCRU) IN CHECKMATE 141, A PHASE 3 STUDY OF NIVOLUMAB VERSUS INVESTIGATOR'S CHOICE (IC) IN PATIENTS WITH RECURRENT OR METASTATIC (R/M) PLATINUM-REFRACTORY SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
    DeRosa, M.
    Cocks, K.
    Taylor, F.
    Bobiak, S.
    Garcia, Juarez A.
    Shaw, J. W.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A113 - A113
12345